Last reviewed · How we verify

Colloidal Bismuth Subcitrate — Competitive Intelligence Brief

Colloidal Bismuth Subcitrate (Colloidal Bismuth Subcitrate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Bismuth-containing antiulcer agent. Area: Gastroenterology.

marketed Bismuth-containing antiulcer agent Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Colloidal Bismuth Subcitrate (Colloidal Bismuth Subcitrate) — Sir Run Run Shaw Hospital. Colloidal bismuth subcitrate forms a protective coating over gastric and duodenal ulcers while also exhibiting antimicrobial activity against Helicobacter pylori.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Colloidal Bismuth Subcitrate TARGET Colloidal Bismuth Subcitrate Sir Run Run Shaw Hospital marketed Bismuth-containing antiulcer agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Bismuth-containing antiulcer agent class)

  1. Sir Run Run Shaw Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Colloidal Bismuth Subcitrate — Competitive Intelligence Brief. https://druglandscape.com/ci/colloidal-bismuth-subcitrate. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: